In the lead up to World Tuberculosis (TB) Day this Saturday, March 24, the TB Alliance announced the launch of a new trial to test a combination drug regimen in patients with drug-sensitive TB as well as patients with multidrug-resistant (MDR) TB – the first time this has ever been done. Called “NC-002,” the eight-week […]
Plan to develop new vaccines could help stop TB in our children’s lifetimes
The following is a guest blog post by Dr. Lucica Ditiu, executive secretary of the Stop TB Partnership, commenting on the newly released document Tuberculosis Vaccines: A Strategic Blueprint for the Next Decade, reflecting the consensus of members of the TB vaccine research and development community to develop new vaccines that could help stop TB in our children’s lifetimes.
HIV
Once outbreak was recognized, program put in place reduced number of ongoing transmissions, modeling shows In 2015, when 181 of rural Scott County, Indiana’s 24,000 residents […]
Tuberculosis
SYDNEY – When Merinda Sebayang was undergoing treatment for multidrug-resistant TB in Indonesia – a nation with the third highest tuberculosis burden in the world after […]
Research & Development
A randomized, multi-country clinical trial testing a regimen for treating drug-resistant tuberculosis in less than a year against the up to two-year regimen recommended by the […]
Policy
The following is a guest post by Ruth Ashton of MEASURE Evaluation CHAPEL HILL, NC―A new study released today in the Lancet’s eClinicalMedicine shows that routine […]